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Purpose of the study
Since the use of more tolerable and less toxic combined
antiretroviral (ARV) therapy, most drug-naïve HIV
patients achieve viral suppression and immunologic
recovery, combined with less AIDS related events. Never-
theless, drug switches are still frequent both as a mean of
adherence and toxicity management and as a response to
virologic or immunologic failure. The aim of the study
was to analyse the number, timing and cause of modifica-
tions in the first ARV regimen in order to elucidate more
about adverse drug reactions in the current HIV ARV
therapy guidelines, indirect signs of adherence and pre-
mature virological failure.
Methods
Non-controlled, observational, retrospective study, based
on the clinical files and on a national questionnaire audit
for all naïve-patients that began cARV therapy between
January 2007 and Mars 2010, followed in an Infectious
Diseases Clinic in a central Hospital in Lisbon. SPSS 15.0
was used for statistical analysis.
Results
During study period, 69 patients of the 285 naïve-patients
who started ARV therapy changed their regimen, 64%
were male, with a median age of 43 years old. A signifi-
cant group was born in African Portuguese speaking
countries (30%). Most switches occurred on the first
6 months (n=42), 22% on the first month and just 11%
after one year of treatment, with more than one modifi-
cation in 15% of patients. The drug regimen prior to
modification included a NNRTI in 62% of the patients.
The back-bone regimen included TDF/FTC in 66%,
ABC/3TC in 12% and still AZT/3TC in 22% of them.
Adverse drug reactions were the most frequent cause of
therapy modification (59%), including toxicity in 19 cases
and intolerability in 22, reflecting the known side effects
of the drugs. Other switch causes were the evidence of
virological failure (15%), the simplification of the regimen
(10%) and the adjustment during pregnancy (5%). About
a fifth of the patients had adherence irregularities. The
rate of viral suppression at week 24 of ARV was signifi-
cantly lower in the group of patients who switched ARV
(39% vs 60%; p=0.006), which had also worse immunolo-
gical recovery at 24 and 48 weeks of ARV.
Conclusions
Toxicity and intolerability remain the main reasons to
change the first ARV regimen, more frequently during
the first to sixth months of therapy, witch reinforce the
need to evaluate early events that can compromise the
adherence, the emergence of resistances and long term
toxicity and longevity of this patients.
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